Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $2.78 billion. The enterprise value is $3.27 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 297.82 million shares outstanding. The number of shares has decreased by -19.45% in one year.
| Current Share Class | 297.82M |
| Shares Outstanding | 297.82M |
| Shares Change (YoY) | -19.45% |
| Shares Change (QoQ) | +18.67% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 75.94% |
| Float | 269.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.10 |
| PS Ratio | 6.28 |
| Forward PS | 3.93 |
| PB Ratio | -15.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.26
| Current Ratio | 4.26 |
| Quick Ratio | 3.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | 324.50 |
| Debt / FCF | n/a |
| Interest Coverage | -5.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.09% |
| Return on Invested Capital (ROIC) | -11.00% |
| Return on Capital Employed (ROCE) | -8.31% |
| Revenue Per Employee | $1.26M |
| Profits Per Employee | -$2.71M |
| Employee Count | 325 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $858,000 in taxes.
| Income Tax | 858,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +167.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +167.82% |
| 50-Day Moving Average | 8.13 |
| 200-Day Moving Average | 11.71 |
| Relative Strength Index (RSI) | 63.07 |
| Average Volume (20 Days) | 10,822,551 |
Short Selling Information
The latest short interest is 47.62 million, so 15.99% of the outstanding shares have been sold short.
| Short Interest | 47.62M |
| Short Previous Month | 47.35M |
| Short % of Shares Out | 15.99% |
| Short % of Float | 17.65% |
| Short Ratio (days to cover) | 3.08 |
Income Statement
In the last 12 months, Core Scientific had revenue of $410.91 million and -$879.79 million in losses. Loss per share was -$3.20.
| Revenue | 410.91M |
| Gross Profit | 63.87M |
| Operating Income | -118.84M |
| Pretax Income | -830.24M |
| Net Income | -879.79M |
| EBITDA | -14.90M |
| EBIT | -118.84M |
| Loss Per Share | -$3.20 |
Full Income StatementBalance Sheet
The company has $697.94 million in cash and $1.19 billion in debt, giving a net cash position of -$496.21 million or -$1.67 per share.
| Cash & Cash Equivalents | 697.94M |
| Total Debt | 1.19B |
| Net Cash | -496.21M |
| Net Cash Per Share | -$1.67 |
| Equity (Book Value) | -181.51M |
| Book Value Per Share | -0.61 |
| Working Capital | 637.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.88 million and capital expenditures -$151.49 million, giving a free cash flow of -$171.37 million.
| Operating Cash Flow | -19.88M |
| Capital Expenditures | -151.49M |
| Free Cash Flow | -171.37M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 15.54%, with operating and profit margins of -28.92% and -229.98%.
| Gross Margin | 15.54% |
| Operating Margin | -28.92% |
| Pretax Margin | -229.77% |
| Profit Margin | -229.98% |
| EBITDA Margin | -3.63% |
| EBIT Margin | -28.92% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 19.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -31.70% |
| FCF Yield | -6.17% |
Analyst Forecast
The average price target for Core Scientific is $19.14, which is 105.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.14 |
| Price Target Difference | 105.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 31.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.36 |
| Piotroski F-Score | 2 |